Ranolazine for Diabetic Peripheral Neuropathic Pain (DPNP)
Condition(s):Diabetic Peripheral Neuropathic PainLast Updated:February 10, 2017Terminated
Hide Studies Not Open or Pending
Condition(s):Diabetic Peripheral Neuropathic PainLast Updated:February 10, 2017Terminated
Condition(s):Coronary Artery Disease; Angina; Metabolic SyndromeLast Updated:July 11, 2013Unknown status
Condition(s):AnginaLast Updated:February 7, 2017Unknown status
Condition(s):HCM – Hypertrophic Non-Obstructive CardiomyopathyLast Updated:December 10, 2020Completed
Condition(s):Atrial FibrillationLast Updated:April 27, 2017Terminated
Condition(s):Cardiomyopathy; Chest Pain; DyspneaLast Updated:March 4, 2020Completed
Condition(s):Dilated CardiomyopathyLast Updated:May 8, 2014Unknown status
Condition(s):Hypertrophic CardiomyopathyLast Updated:March 3, 2017Completed
Condition(s):Microvascular AnginaLast Updated:May 16, 2017Completed
Condition(s):Myocardial StunningLast Updated:February 25, 2021Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.